Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Molecular Pharmacology
|
March 13, 2008
Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening
Franck Madoux, Xiaolin Li, Peter Chase, et al.
Biological & Pharmaceutical Bulletin
|
December 15, 2024
Pharmacological Properties of JTE-151; A Novel Orally Available RORγ Antagonist That Suppresses Th17 Cell-Related Responses <i>in Vitro</i> and <i>in Vivo</i>
Kojo Arita, Haiyan Tao, Paul Crowe, et al.
Scientific Reports
|
November 28, 2018
Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction
Masato Noguchi, Akihiro Nomura, Satoki Doi, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 10, 2025
A potent and selective RORγ inhibitor for the treatment of autoimmune diseases
Taku Ikenogami, Masahiro Yokota, Shingo Fujioka, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
May 12, 2017
Ternary complex of human RORγ ligand-binding domain, inverse agonist and SMRT peptide shows a unique mechanism of corepressor recruitment
Masato Noguchi, Akihiro Nomura, Ken Murase, et al.
Journal of Medicinal Chemistry
|
February 19, 2019
Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold
Masayuki Kotoku, Takaki Maeba, Shingo Fujioka, et al.
ACS Medicinal Chemistry Letters
|
January 29, 2016
SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious RORγ Inhibitor
Kazuyuki Hirata, Masayuki Kotoku, Noriyoshi Seki, et al.
Journal of Medicinal Chemistry
|
July 18, 2025
A Concise and Modular Approach to Generate Novel RORγ Agonists
Shunichi Fukuda, Taku Ikenogami, Kazuki Otake, et al.
Journal of Medicinal Chemistry
|
January 3, 2024
Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development
Takaki Maeba, Kazuyuki Hirata, Masayuki Kotoku, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Molecular Pharmacology
|
March 13, 2008
Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening
Franck Madoux, Xiaolin Li, Peter Chase, et al.
Biological & Pharmaceutical Bulletin
|
December 15, 2024
Pharmacological Properties of JTE-151; A Novel Orally Available RORγ Antagonist That Suppresses Th17 Cell-Related Responses <i>in Vitro</i> and <i>in Vivo</i>
Kojo Arita, Haiyan Tao, Paul Crowe, et al.
Scientific Reports
|
November 28, 2018
Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction
Masato Noguchi, Akihiro Nomura, Satoki Doi, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 10, 2025
A potent and selective RORγ inhibitor for the treatment of autoimmune diseases
Taku Ikenogami, Masahiro Yokota, Shingo Fujioka, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
May 12, 2017
Ternary complex of human RORγ ligand-binding domain, inverse agonist and SMRT peptide shows a unique mechanism of corepressor recruitment
Masato Noguchi, Akihiro Nomura, Ken Murase, et al.
Journal of Medicinal Chemistry
|
February 19, 2019
Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold
Masayuki Kotoku, Takaki Maeba, Shingo Fujioka, et al.
ACS Medicinal Chemistry Letters
|
January 29, 2016
SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious RORγ Inhibitor
Kazuyuki Hirata, Masayuki Kotoku, Noriyoshi Seki, et al.
Journal of Medicinal Chemistry
|
July 18, 2025
A Concise and Modular Approach to Generate Novel RORγ Agonists
Shunichi Fukuda, Taku Ikenogami, Kazuki Otake, et al.
Journal of Medicinal Chemistry
|
January 3, 2024
Discovery and SAR of JTE-151: A Novel RORγ Inhibitor for Clinical Development
Takaki Maeba, Kazuyuki Hirata, Masayuki Kotoku, et al.
Page
of 1